×

Presenter

Narelle Williams



Presentations by Narelle Williams
A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma (I-MAT Trial)
A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma (I-MAT Trial)
Wen Xu, Michael Poulsen, Victoria Atkinson, Gerald Fogarty, Michael Veness


No presentations found for today.